The Competitive Enterprise Institute believes the proper role for government is to provide consumers with accurate, unbiased guidance that informs consumer choice. But, whether it is the substances we prefer, how we entertain ourselves, what dietary habits we maintain, or how we pursue personal health, consumers ought to have the right to make decisions for themselves.
Consumer Freedom Issue Areas
Featured Posts
Blog
Illiberalism: The bipartisan tradition
After experiencing the horrors of World War I and fearing a second World War could be imminent, Ludwig von Mises wrote Liberalism: The Classical…
Blog
The Senate housing bill’s road to socialism
In the last week of February, I expressed hope that members of Congress would “embrace free-market proposals to advance opportunities in the housing sector”…
Blog
No free lunch: Price controls won’t make groceries more affordable
When Americans go to the grocery store, they expect to find food and drinks. Lately, many are encountering something else: sticker shock. According to…
Search Posts
Blog
Conservatarian Thoughts on the FCC
Our friend (and former Open Market editor) Peter Suderman makes an excellent free market point at The Corner today about broadcast obscenity and…
Blog
NYT on Carson
Today, columnist John Tierney takes on the legacy of Rachel Carson in the New York Times Science section, offering a critique of Carson’s alarmism and…
Blog
Greens Attack Rather than Debate
Environmental activists from Environmental Defense, the Pesticide Action Network of North America (PANNA), and the Silent Spring Institute refuse to debate me (and probably anyone…
Blog
Rachel wrong on NRO and CBS
Iain’s National Review Online piece on Rachel Carson’s other legacy — alarmism as a political tactic — was also picked up by CBS…
Blog
At the Mercy of Regulators
After a seven-year policy battle, Europe’s new chemical law takes effect today. The law is known as REACH—the acronym for the bureaucratic name Registration, Evaluation…
Blog
Tensions within the FDA — Type I, Type II debate
An internecine struggle apparently exists within the FDA, according to an article in the New York Times. Those tensions between drug approval officials and…